Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for GERN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 1996. Start Trial.
Date Value
December 31, 2025 359.80M
December 31, 2024 408.43M
December 31, 2023 334.81M
December 31, 2022 173.11M
December 31, 2021 184.09M
December 31, 2020 196.64M
December 31, 2019 139.60M
December 31, 2018 163.56M
December 31, 2017 94.95M
December 31, 2016 115.11M
December 31, 2015 114.04M
December 31, 2014 151.71M
December 31, 2013 66.02M
December 31, 2012 96.33M
December 31, 2011 122.11M
Date Value
December 31, 2010 187.36M
December 31, 2009 112.40M
December 31, 2008 163.66M
December 31, 2007 208.44M
December 31, 2006 213.86M
December 31, 2005 191.00M
December 31, 2004 120.49M
December 31, 2003 109.78M
December 31, 2002 47.52M
December 31, 2001 69.47M
December 31, 2000 33.02M
December 31, 1999 39.29M
December 31, 1998 24.47M
December 31, 1997 21.60M
December 31, 1996 24.27M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Precigen, Inc. 97.86M
Editas Medicine, Inc. 146.64M
Agenus, Inc. 2.998M
Amgen, Inc. 9.129B
Anika Therapeutics, Inc. 57.48M